Dresden, Germany

Cenix Bioscience Gmbh

Calculating rank
USPTO Granted Patents = 4

% Expired Patents = 100.0


Forward Citations = 2

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Anthony A Hyman (3 out of 6 patents)

silverMedal Steven J Jones (3 out of 24 patents)

bronzeMedal Christophe Echeverri (3 out of 3 patents)

4.  Birte Sönnichsen (2 out of 2 patents)

5.  Pierre Gönczy (2 out of 2 patents)

6.  Andrew Walsh (2 out of 2 patents)

7.  Liisa Koski (2 out of 2 patents)

8.  Michael Hannus (1 out of 2 patents)

9.  Maria M Mota (1 out of 4 patents)

10.  Cecilie Martin (1 out of 1 patent)

11.  Miguel Prudencio (1 out of 1 patent)

12.  Christina Dias Rodrigues (1 out of 1 patent)

13.  Pierre Goenczy (1 out of 1 patent)

14.  Karen Oegema (1 out of 2 patents)

15.  Matthew Kirkham (1 out of 1 patent)


4 patents:

Company Overview
Cenix Bioscience Gmbh is a leading contract research organization specializing in preclinical services for drug discovery and development. With a focus on RNAi-based high-throughput screening and functional genomics, Cenix offers a wide range of innovative solutions for target validation, biomarker discovery, and mechanism of action studies. Their team of experienced scientists provides customized research services to pharmaceutical and biotechnology companies worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

4 Patents

#67 in Dresden

#7,064 in Germany

Dresden, DE
Dresden, Germany
Forward Citations = 2

15 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cenix Bioscience Gmbh. Retrieved from https://idiyas.com/company/cenix-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…